Next Article in Journal
A Label-Free Microelectrode Array Based on One-Step Synthesis of Chitosan–Multi-Walled Carbon Nanotube–Thionine for Ultrasensitive Detection of Carcinoembryonic Antigen
Next Article in Special Issue
Distribution of Iron Oxide Core-Titanium Dioxide Shell Nanoparticles in VX2 Tumor Bearing Rabbits Introduced by Two Different Delivery Modalities
Previous Article in Journal
Nanostructures Derived from Starch and Chitosan for Fluorescence Bio-Imaging
Previous Article in Special Issue
Soft Interaction in Liposome Nanocarriers for Therapeutic Drug Delivery
Article Menu

Export Article

Open AccessReview
Nanomaterials 2016, 6(7), 131; doi:10.3390/nano6070131

Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer

1
Department of Pharmacy, University Federico II of Naples, Via Domenico Montesano 49, 80131 Naples, Italy
2
Institute of Molecular Sciences, CNRS, Université Paris-Sud, Université Paris Saclay, 91400 Orsay, France
3
Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, 80138 Naples, Italy
*
Author to whom correspondence should be addressed.
Academic Editor: Luigi Pasqua
Received: 4 May 2016 / Revised: 16 June 2016 / Accepted: 1 July 2016 / Published: 9 July 2016
(This article belongs to the Special Issue Nanomaterials for Cancer Therapies)
View Full-Text   |   Download PDF [714 KB, uploaded 9 July 2016]   |  

Abstract

The growing knowledge on the mechanisms of gene silencing and gene regulation by non-coding RNAs (ncRNA), mainly small interfering RNA (siRNA) and microRNA (miRNA), is providing a significant boost to the development of new therapeutic strategies for the treatment of cancer. However, the design of RNA-based therapeutics is hampered by biopharmaceutical issues, thus requiring the use of suitable delivery strategies. In this regards, lipid nanovectors have been successfully investigated to deliver RNA in different forms of cancer. Compared to other biomaterials, lipids offer advantages such as biocompatibility, biodegradability, easy production, low cost, limited toxicity and immunogenicity. The possibility to formulate these materials in the form of nanovectors allows overcoming biopharmaceutical issues associated to the therapeutic use of RNA, with the possibility to target tumors. This review takes stock of the main lipid nanovectors proposed to deliver ncRNA. For each considered delivery strategy, the rational design and the most meaningful in vitro and in vivo results are reported and discussed. View Full-Text
Keywords: nucleic acid; cationic liposomes; stable nucleic acid lipid particles (SNALPs); lipid-nanoparticles; micelles nucleic acid; cationic liposomes; stable nucleic acid lipid particles (SNALPs); lipid-nanoparticles; micelles
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Campani, V.; Salzano, G.; Lusa, S.; De Rosa, G. Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer. Nanomaterials 2016, 6, 131.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nanomaterials EISSN 2079-4991 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top